Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristics.
| Image |  |
|---|---|
| Description | scientific article published on 20 November 2009 |
| Author/s |
author: Bertrand Tombal Laurent Boccon-Gibod |
| Publication date | November 20, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |